Trials / Completed
CompletedNCT03099304
A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of INCB018424 Phosphate Cream in Subjects With Vitiligo
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 157 (actual)
- Sponsor
- Incyte Corporation · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study will be to examine the efficacy, safety, and tolerability of ruxolitinib cream in subjects with vitiligo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ruxolitinib cream | Ruxolitinib cream is a topical formulation applied as a thin film to affected areas. |
| DRUG | Vehicle cream | Vehicle cream is matching in appearance to ruxolitinib cream and is to be applied in the same manner as ruxolitinib cream. |
Timeline
- Start date
- 2017-06-07
- Primary completion
- 2018-09-12
- Completion
- 2021-09-08
- First posted
- 2017-04-04
- Last updated
- 2022-11-17
- Results posted
- 2021-12-10
Locations
26 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03099304. Inclusion in this directory is not an endorsement.